Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

por Kümmel, S, Krocker, J, Kohls, A, Breitbach, G-P, Morack, G, Budner, M, Blohmer, J-U, Elling, D
Publicado 2006

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

por Ortmann, O., Blohmer, J.-U., Sibert, N. T., Brucker, S., Janni, W., Wöckel, A., Scharl, A., Dieng, S., Ferencz, J., Inwald, E. C., Wesselmann, S., Kowalski, C.
Publicado 2022